LLY vs NXRT · P/E 39, rev $22.97B vs rev $128.2M
Eli Lilly and Company (LLY) versus Nexpoint Residential Trust Inc (NXRT) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Nexpoint Residential Trust Inc (NXRT) is a reit - residential company listed on US.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported NXRT revenue for 2026-06-30 was $128.2M. Net income was -$15.4M. NXRT currently screens at market cap $1.50B.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. NXRT currently screens at market cap $1.50B.
Not investment advice. Open the LLY and NXRT stock pages for the full models.
Not investment advice.